nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—CHRM1—Monoamine GPCRs—DRD4—conduct disorder	0.0497	0.0497	CbGpPWpGaD
Mepenzolate—CHRM3—Monoamine GPCRs—DRD4—conduct disorder	0.0496	0.0496	CbGpPWpGaD
Mepenzolate—CHRM2—Monoamine GPCRs—DRD4—conduct disorder	0.0491	0.0491	CbGpPWpGaD
Mepenzolate—CHRM1—Amine ligand-binding receptors—DRD4—conduct disorder	0.0418	0.0418	CbGpPWpGaD
Mepenzolate—CHRM3—Amine ligand-binding receptors—DRD4—conduct disorder	0.0417	0.0417	CbGpPWpGaD
Mepenzolate—CHRM2—Amine ligand-binding receptors—DRD4—conduct disorder	0.0413	0.0413	CbGpPWpGaD
Mepenzolate—CHRM1—Monoamine GPCRs—HTR2A—conduct disorder	0.0324	0.0324	CbGpPWpGaD
Mepenzolate—CHRM3—Monoamine GPCRs—HTR2A—conduct disorder	0.0323	0.0323	CbGpPWpGaD
Mepenzolate—CHRM2—Monoamine GPCRs—HTR2A—conduct disorder	0.032	0.032	CbGpPWpGaD
Mepenzolate—CHRM1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0273	0.0273	CbGpPWpGaD
Mepenzolate—CHRM3—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0272	0.0272	CbGpPWpGaD
Mepenzolate—CHRM2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0269	0.0269	CbGpPWpGaD
Mepenzolate—CHRM3—GPCRs, Other—DRD4—conduct disorder	0.022	0.022	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Other—DRD4—conduct disorder	0.0218	0.0218	CbGpPWpGaD
Mepenzolate—CHRM1—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0213	0.0213	CbGpPWpGaD
Mepenzolate—CHRM3—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.0212	0.0212	CbGpPWpGaD
Mepenzolate—CHRM2—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.021	0.021	CbGpPWpGaD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0151	0.0151	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0147	0.0147	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0146	0.0146	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0145	0.0145	CbGpPWpGaD
Mepenzolate—CHRM3—GPCRs, Other—HTR2A—conduct disorder	0.0144	0.0144	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Other—HTR2A—conduct disorder	0.0142	0.0142	CbGpPWpGaD
Mepenzolate—CHRM1—Circadian rythm related genes—SLC6A4—conduct disorder	0.0125	0.0125	CbGpPWpGaD
Mepenzolate—CHRM1—Circadian rythm related genes—DRD4—conduct disorder	0.0117	0.0117	CbGpPWpGaD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.0113	0.0113	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—CGA—conduct disorder	0.0112	0.0112	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—CGA—conduct disorder	0.0111	0.0111	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.011	0.011	CbGpPWpGaD
Mepenzolate—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.0102	0.0102	CbGpPWpGaD
Mepenzolate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0096	0.0096	CbGpPWpGaD
Mepenzolate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00956	0.00956	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00947	0.00947	CbGpPWpGaD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00924	0.00924	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00822	0.00822	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00819	0.00819	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00812	0.00812	CbGpPWpGaD
Mepenzolate—CHRM1—G alpha (q) signalling events—HTR2A—conduct disorder	0.0081	0.0081	CbGpPWpGaD
Mepenzolate—CHRM3—G alpha (q) signalling events—HTR2A—conduct disorder	0.00807	0.00807	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00724	0.00724	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00722	0.00722	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—CGA—conduct disorder	0.00632	0.00632	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—CGA—conduct disorder	0.0063	0.0063	CbGpPWpGaD
Mepenzolate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00626	0.00626	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—DRD4—conduct disorder	0.00626	0.00626	CbGpPWpGaD
Mepenzolate—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00624	0.00624	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—DRD4—conduct disorder	0.00624	0.00624	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.00624	0.00624	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00618	0.00618	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.00618	0.00618	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CGA—conduct disorder	0.00574	0.00574	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CGA—conduct disorder	0.00572	0.00572	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.00566	0.00566	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00536	0.00536	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00535	0.00535	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00529	0.00529	CbGpPWpGaD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.0049	0.0049	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	0.00408	0.00408	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	0.00407	0.00407	CbGpPWpGaD
Mepenzolate—CHRM1—Circadian rythm related genes—EP300—conduct disorder	0.00405	0.00405	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CGA—conduct disorder	0.00404	0.00404	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	0.00403	0.00403	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	0.00354	0.00354	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	0.00353	0.00353	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	0.00349	0.00349	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CGA—conduct disorder	0.00339	0.00339	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CGA—conduct disorder	0.00338	0.00338	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CGA—conduct disorder	0.00335	0.00335	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—DRD4—conduct disorder	0.00321	0.00321	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—DRD4—conduct disorder	0.0032	0.0032	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—DRD4—conduct disorder	0.00317	0.00317	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—WASF1—conduct disorder	0.00272	0.00272	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—WASF1—conduct disorder	0.00271	0.00271	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—WASF1—conduct disorder	0.00268	0.00268	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	0.00231	0.00231	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	0.0023	0.0023	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	0.00228	0.00228	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	0.0021	0.0021	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	0.00209	0.00209	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	0.00207	0.00207	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—DRD4—conduct disorder	0.0019	0.0019	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—DRD4—conduct disorder	0.00189	0.00189	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—DRD4—conduct disorder	0.00187	0.00187	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—COMT—conduct disorder	0.00182	0.00182	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—MAOA—conduct disorder	0.00181	0.00181	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HTR2A—conduct disorder	0.00124	0.00124	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HTR2A—conduct disorder	0.00123	0.00123	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HTR2A—conduct disorder	0.00122	0.00122	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—EP300—conduct disorder	0.000782	0.000782	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—EP300—conduct disorder	0.000656	0.000656	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—EP300—conduct disorder	0.000654	0.000654	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—EP300—conduct disorder	0.000648	0.000648	CbGpPWpGaD
